BioDelivery Sciences International, Inc. has relocated its corporate headquarters from Morrisville to Raleigh N.C., effective November 1, 2007. The new space will encompass approximately 5500 square feet of office space.

“The move to a new corporate headquarters will provide us with the necessary space to accommodate the additional employees that we have hired to manage the activities associated with follow up to the BEMA Fentanyl NDA submission and the future hires we are anticipating in 2008 and beyond necessary for managing the needs around the progression of other products in our pipeline,” said Dr. Mark Sirgo, President and CEO of BDSI.

BDSI’s accounting office in Tampa, Fla., and its laboratory in Newark, N.J., (which is utilized primarily for development of the company’s Bioral drug delivery technology) will remain at their present locations.

BioDelivery Sciences International, Inc. is a specialty pharmaceutical company that is focused on developing innovative products to treat acute conditions such as pain. The company’s headquarters are located in Raleigh, North Carolina and its principal laboratory is located in Newark, N.J.

For MORE NEWS BRIEFS, click here.

For a FREE SUBSCRIPTION to Expansion Management magazine, click here.

For MORE NEWS BRIEFS SORTED BY STATE, click here.

For MORE NEWS BRIEFS SORTED BY INDUSTRY or FUNCTION, click here.

For MORE NEWS BRIEFS SORTED BY COUNTRY, click here.